CHEMOTHERAPY INDUCED HAIR LOSS
at reducing hair loss
in chemotherapy patients
Hair loss is one of the most difficult aspects of cancer treatment. Chemotherapy attacks fast dividing cells, including hair cells, causing rapid hair loss within weeks of starting treatment.
Designed to use low-level compression therapy on the surface of the scalp.
Lily is currently entering clinical trials in Europe. It is not released for commercial use.
CHEMOTHERAPY INDUCED PERIPHERAL NEUROPATHY
to reduce the
onset of peripheral neuropathy
Chemotherapy induced peripheral neuropathy (CIPN) is the loss of sensory and motor function caused by nerve damage associated with chemotherapy.